The challenge
A competitor vaccine manufacturer recently put a temporary hold on their vaccine development program, requiring Putnam’s client to update their global commercial forecast to account for a range of potential competitive launch scenarios. The forecast would be used to inform commercial strategy and supply chain decisions.
Our solution
Research objectives:
- Assess likelihood to recommend, stock vaccine across patient types and scenarios
- Quantify willingness to accept the vaccine based on variations in out-of-pocket cost and HCP recommendation
- Understand likelihood of protocol inclusion (LTC) and stocking likelihood (LTC + pharmacy)
Our approach:
We conducted four key research studies in US, EU5, and Japan:
- HCP Quantitative Demand Study
- Patient Quantitative Willingness to Pay Study
- Pharmacy Stakeholder Interviews
- Long-term Care Stakeholder Interviews
Both quantitative studies used a monadic design approach to test the impact of several competitive scenarios.
The results
Putnam delivered the findings and forecast inputs through a series of workshops with various client teams. This built alignment around the updated competitive landscape and helped team confidently make changes to their strategy.
Jump to a slide with the slide dots.
Jo Ann Saitta
Accelerated Real-World Insight: How AI and Claims Data Rapidly Turn Gaps into Health Equity Action
AI and claims data bridge health equity gaps in cardiovascular care, uncovering disparities and providing actionable solutions to improve access.
Read morePatient Finding Through Data Tokenization
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Read moreDigital share of voice and sentiment analysis at key congress
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Read more